Opus Genetics IRD EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Opus Genetics’s reported figures.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's EBITDA?
- Opus Genetics (IRD) reported EBITDA of -$14.35M in Q1 2026.
- How has Opus Genetics's EBITDA changed year-over-year?
- Opus Genetics's EBITDA decreased by 44.7% year-over-year, from -$9.92M to -$14.35M.
- What is the long-term trend for Opus Genetics's EBITDA?
- Over 4 years (2021 to 2025), Opus Genetics's EBITDA has grown at a 14.2% compound annual growth rate (CAGR), from -$22.7M to -$38.55M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.